2011
DOI: 10.1118/1.3644843
|View full text |Cite
|
Sign up to set email alerts
|

Dosimetry of a new P‐32 ophthalmic applicator

Abstract: The P-32 applicator can deliver therapeutic doses to the surface of the conjunctiva, while sparing the lens better than Sr∕Y-90 applicators. The doses at any points from the P-32 applicator could be calculated by using the measured dosimetry data. They also confirmed no leakage of the source, reliable integrity of the applicator, and negligible exposure level around the hand grip of the applicator. However, due to a possibility of nonuniform distributions of P-32 in an absorbent disk, measuring dose profiles a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 26 publications
(43 reference statements)
0
2
0
Order By: Relevance
“…Brachytherapy treatments can be classified according to different criteria including, implant methods, implant duration, loading systems, and radiation dose rate delivered by β and γ emission [3,4]. In comparison to the gamma emitter sources, β-emitters are proper candidates for some types of brachytherapy treatment (such as in intravascular coronary brachytherapy, treatment of metastatic uveal melanoma, and treatment of malignant hepatic lesions) due to the short range of electrons in tissue, resulting in a rapid decrease of deposited energy with a distance, with a sharp dose gradient [5,6]. 106Ru/106Rh, 90Sr/90Y, 90Y, and 32P are some common type of β-emitting radionuclides, which have good properties for the use in brachytherapy.…”
Section: Purposementioning
confidence: 99%
See 1 more Smart Citation
“…Brachytherapy treatments can be classified according to different criteria including, implant methods, implant duration, loading systems, and radiation dose rate delivered by β and γ emission [3,4]. In comparison to the gamma emitter sources, β-emitters are proper candidates for some types of brachytherapy treatment (such as in intravascular coronary brachytherapy, treatment of metastatic uveal melanoma, and treatment of malignant hepatic lesions) due to the short range of electrons in tissue, resulting in a rapid decrease of deposited energy with a distance, with a sharp dose gradient [5,6]. 106Ru/106Rh, 90Sr/90Y, 90Y, and 32P are some common type of β-emitting radionuclides, which have good properties for the use in brachytherapy.…”
Section: Purposementioning
confidence: 99%
“…Choi et al . [6] provided experimental simulation of the dosimetric characteristics of a new 32P ophthalmic applicator.…”
Section: Purposementioning
confidence: 99%